Manufacturing Infrastructure

cGMP Synthesis Facility

Our Antwerp production site operates ISO Class 5 crystallization suites and automated micronisation systems, producing pharmacopeial bulk powders for formulation manufacturers worldwide.

Batch Lifecycle

Four Validation Phases

01
02
03
04

Intermediate Assay Screening

Controlled Crystallization

Micronisation and Sizing

Final Monograph Release

Automated thermal cycles guide sterile crystallization, controlling crystal polymorph structures and preliminary particle size distributions within dedicated stainless reactors.

Jet milling technology calibrates particle size distributions to client monograph specifications under sealed laminar flow hoods with zero ambient exposure.

Independent QA audits HPLC assay purities, residual solvents, and endotoxin levels before issuing accredited Certificates of Analysis for export.

Incoming raw chemical precursors undergo spectroscopic assay verification and trace solvent screening prior to cleanroom reactor loading under sterile inert gas.

Analytical Instrumentation

Dedicated In-House Laboratories

Every synthesis campaign undergoes rigorous chromatographic testing in our on-site analytical suites. Our QA chemists deploy validated HPLC, GC-MS, and laser diffraction analyzers to verify chemical purity standards.

Complete regulatory dossiers including CEP filings and Type II DMF documents accompany our commercial shipments, ensuring seamless regulatory compliance for qualified international drug manufacturing plants.

Quality Protocol

Purity Without Compromise

We maintain uncompromised chemical purity standards, verified batch traceability, and comprehensive documentation for every container dispatched across international trade lanes.

Schedule Quality Audits

Coordinate on-site plant inspections or secure virtual facility audits with our regulatory affairs and technical quality assurance teams.